Hong Kong Gas Utilities Stock News

SEHK:6938
SEHK:6938Biotechs

Suzhou Ribo Life Science (SEHK:6938) Valuation Check After Recent Share Price Weakness

Why Suzhou Ribo Life Science Is Drawing Investor Attention Suzhou Ribo Life Science (SEHK:6938) has come onto investors’ radar after a month return of about 8% decline, extending a weaker year to date performance and raising fresh questions about sentiment toward its small nucleic acid drug pipeline. See our latest analysis for Suzhou Ribo Life Science. The latest 1 day share price return of a 5.40% decline, on a last close of HK$70.05, sits against a 7 day share price return of 1.08% and a...
SEHK:9926
SEHK:9926Biotechs

Assessing Akeso (SEHK:9926) Valuation After AK139 Trial Approval And Ivonescimab Breakthrough Designation

Akeso (SEHK:9926) has just received approval in China to start Phase II trials for AK139, a first in class IL-4Ra/ST2 bispecific antibody, targeting seven respiratory and autoimmune conditions. See our latest analysis for Akeso. Investors seem to be weighing Akeso's busy clinical calendar against recent volatility, with a 1 day share price return of 1.54% and 7 day return of 4.36% following the AK139 and ivonescimab updates. The 1 year total shareholder return of 74.92% points to strong...
SEHK:9966
SEHK:9966Biotechs

Assessing Alphamab Oncology (SEHK:9966) Valuation After JSKN003 Phase III Trial Patient Dosing Milestone

Alphamab Oncology (SEHK:9966) has dosed the first patient in its Phase III trial of JSKN003 for HER2-positive advanced colorectal cancer, marking a key milestone for this antibody-drug conjugate following its Breakthrough Therapy Designation in China. See our latest analysis for Alphamab Oncology. The JSKN003 milestone comes after a mixed run in the shares, with a 1-year total shareholder return of 124.81% contrasting with a 30-day share price return decline of 12.74% and longer term 3 and 5...
SEHK:981
SEHK:981Semiconductor

How SMIC’s Q4 Profit and Flat Q1 Margin Outlook Will Impact Semiconductor Manufacturing International (SEHK:981) Investors

Semiconductor Manufacturing International Corporation reported fourth-quarter 2025 results with sales of US$2,488.71 million and net income of US$172.85 million, and later issued first-quarter 2026 guidance indicating sequentially flat revenue and an 18%–20% gross margin range. This combination of solid quarterly profitability and a cautious margin outlook gives investors fresh insight into how SMIC is balancing growth with profitability pressures. Next, we’ll examine how SMIC’s guidance for...
SEHK:1211
SEHK:1211Auto

Assessing BYD (SEHK:1211) Valuation As Shares Rebuild Short Term Momentum

BYD stock performance snapshot BYD (SEHK:1211) has recently seen mixed share performance, with a 0.8% decline over the past day, a 5.9% gain over the past week, and a small pullback over the past month. Over longer periods, BYD shows a 1.0% negative return year to date, an 18.6% negative total return over the past year, and positive total returns across the past 3 and 5 years, highlighting both volatility and staying power. The shares last closed at HK$97.75, with recent annual revenue of...
SEHK:992
SEHK:992Tech

Lenovo Reshapes Infrastructure Group For AI As Shares Trade Below Targets

Lenovo Group (SEHK:992) is restructuring its Infrastructure Solutions Group to place greater emphasis on AI driven offerings. The company is expanding AI centric products and services while dealing with an industry wide crunch in memory chip supply. Management is prioritizing cost savings and new AI enabled hardware and infrastructure solutions to adapt its operations and product mix. For you as an investor, the key point is that Lenovo is reshaping a core infrastructure business around AI...
SEHK:1299
SEHK:1299Insurance

AIA Group Adds Industry Veterans To Board As Governance Priorities Evolve

AIA Group (SEHK:1299) has appointed Ms. Shulamite Khoo and Mr. Ku Man as Independent Non executive Directors. Both appointees bring extensive experience across insurance, banking and international executive roles. Their appointments expand the board’s mix of industry, financial and governance expertise. AIA Group focuses on life and health insurance, with a footprint across multiple Asia Pacific markets. Fresh board appointments are often closely watched by investors, as they can influence...
SEHK:23
SEHK:23Banks

Bank Of East Asia SEHK 23 Margin Compression Challenges Bullish Earnings Growth Narrative

Bank of East Asia (SEHK:23) has just posted its FY 2025 first half results, with total revenue of HK$7.7b and basic EPS of HK$0.86, alongside net income of HK$2.3b. The bank reported revenue of HK$7.5b and EPS of HK$0.69 in the first half of 2024, followed by revenue of HK$7.9b and EPS of HK$0.84 in the second half of 2024. As a result, FY 2025 starts after three consecutive reported periods of higher earnings per share. With that backdrop, investors are likely to focus on how its net...
SEHK:3690
SEHK:3690Hospitality

Assessing Meituan’s Valuation As FY2025 Loss Guidance Follows FY2024 Profit And Heavier Competition Spending

Why Meituan’s New Guidance Matters for Shareholders Meituan (SEHK:3690) has guided for a FY2025 loss of RMB 23,300 million to RMB 24,300 million, after reporting a FY2024 profit of RMB 35,808 million, as competition pushes the company to raise ecosystem investment. The guidance also points to a shift in the Core Local Commerce segment, from a RMB 52,415 million operating profit in FY2024 to an expected operating loss of RMB 6,800 million to RMB 7,000 million, alongside heavier spending on...
SEHK:2252
SEHK:2252Medical Equipment

Shanghai MicroPort MedBot (SEHK:2252) Valuation After Global Toumai Robot Orders And Remote Surgery Progress

Shanghai MicroPort MedBot (Group) (SEHK:2252) is back on investors’ radar after reporting more than 200 commercial orders for its Toumai laparoscopic surgical robot, with around 130 systems installed across nearly 50 countries and regions. See our latest analysis for Shanghai MicroPort MedBot (Group). The recent Toumai order momentum and remote surgery progress come as the shares trade at HK$29.0, with an 11.71% 1 day share price return and 22.99% 90 day share price return, alongside a 50.57%...
SEHK:489
SEHK:489Auto

A Look At Dongfeng Motor Group (SEHK:489) Valuation After The Carro And Volt Auto Southeast Asia Showroom Deal

Why Dongfeng Motor Group Stock Is Back on Investor Radars After the Carro Deal Dongfeng Motor Group (SEHK:489) is drawing fresh attention after Carro became an authorised dealer for Dongfeng Motor Corporation, opening exclusive showrooms in Singapore and Malaysia in partnership with Volt Auto. This push into Southeast Asia, backed by integrated financing, insurance, and planned 3S facilities in Malaysia, gives investors a new angle to think about how Dongfeng’s regional reach and customer...
SEHK:175
SEHK:175Auto

Is Geely Automobile Holdings (SEHK:175) Share Price Weakness Creating A Long-Term Opportunity?

If you are wondering whether Geely Automobile Holdings is attractively priced right now, you are not alone. This article is built around that exact question. The stock closed at HK$16.97 recently, with returns of 4.0% over 7 days, 0.9% over 1 year, 56.7% over 3 years and a 36.6% decline over 5 years, while year to date it is down 6.8%. These mixed returns have kept Geely on many watchlists, with investors weighing shorter term moves against a much stronger 3 year performance. Broader...
SEHK:3738
SEHK:3738Software

Vobile Group (SEHK:3738) Valuation Check After Finloop IP Tokenization Collaboration

Vobile Group (SEHK:3738) has drawn fresh attention after announcing a collaboration with Finloop Finance Technology to tokenize offshore real world assets tied to cultural and creative intellectual property, with the aim of building a compliant IP backed digital asset ecosystem. See our latest analysis for Vobile Group. The Finloop agreement lands at a time when momentum in Vobile Group’s shares has been picking up, with a 7 day share price return of 37.09% and a year to date share price...